Vortioxetine Induced Hypomania: A Case Presentation and Review of the Literature
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Antidepressant-induced hypomania/mania is a complex issue that can be seen in mood disorders but is not clarified. There are case reports in the literature regarding vortioxetine-induced mania and hypomania; however, there is insufficient data. Here, we aim to present a case of vortioxetine-induced hypomania in a major depressive disorder patient who previously used various antidepressants but did not experience hypomania or mania. Our case is expected to contribute to the literature.
Abstract
Antidepressant-induced hypomania/mania is a complex issue that can be seen in mood disorders but is not clarified. There are case reports in the literature regarding vortioxetine-induced mania and hypomania; however, there is insufficient data. Here, we aim to present a case of vortioxetine-induced hypomania in a major depressive disorder patient who previously used various antidepressants but did not experience hypomania or mania. Our case is expected to contribute to the literature.
참고문헌 (27)
- Baldessarini RJ, "Antidepressant-associated moodswitching and transition from unipolar major depression to bipolar disorder : a review", J Affect Disord, 148, pp.129~135 (2013)
- Barbuti M, "Antidepressant-induced hypomania", mania in patients with major depression : evidence from the BRIDGEII-MIX study, 2017, pp.219, 187~192
- Navarro V, "Treatment and outcome of antidepressant treatment-associated hypomania in unipolar major depression : a 3-year follow-up study", J Affect Disord, 155, pp.59~64 (2014)
- Valentí M, "Risk factors for antidepressant-related switch to mania", J Clin Psychiatry, 73, pp.e271~e276 (2012)
- Gill N, "A review of antidepressant-associated hypomania in those diagnosed with unipolar depression-risk factors, conceptual models, and management", Curr Psychiatry Rep, 22, pp.20~ (2020)
- Bennabi D, "Vortioxetine for cognitive enhancement in major depression : from animal models to clinical research", Front Psychiatry, 10, pp.771~ (2019)
- Atique-Ur-Rehman H, "Cognitive dysfunction in major depression : from assessment to novel therapies", Pharmacol Ther, 202, pp.53~71 (2019)
- Salagre E, "Vortioxetine: a new alternative for the treatment of major depressive disorder", Rev Psiquiatr Salud Ment(Engl Ed), 11, pp.48~59 (2018)
- Chun BJ, "A review of antidepressant-induced hypomania in major depression : suggestions for DSM-V", Bipolar Disord, 6, pp.32~42 (2004)
- Sanchez C, "Vortioxetine, a novel antidepressant with multimodal activity : review of preclinical and clinical data", Pharmacol Ther, 145, pp.43~57 (2015)
- Sowa-Kućma M, "Vortioxetine : a review of the pharmacology and clinical profile of the novel antidepressant", Pharmacol Rep, 69, pp.595~601 (2017)
- Maud C, "Vortioxetine in bipolar depression induces a mixed", manic switch, 2016, pp.24, 206~207
- Aydın EP, "Hypomanic switch during vortioxetine treatment : a case report", Psychiatry Clin Psychopharmacol, 29, pp.114~116 (2019)
- Baldwin DS, "The safety and tolerability of vortioxetine : analysis of data from randomized placebo-controlled trials and open-label extension studies", J Psychopharmacol, 30, pp.242~252 (2016)
- D’Andrea G, "Vortioxetine treatment-emergent mania in the elderly : a case report", Australas Psychiatry, 27, pp.413~ (2019)
- Sobreira G, "Vortioxetine-induced manic mood switch in patient with previously unknown bipolar disorder", Braz J Psychiatry, 39, pp.86~ (2017)
- De Carlo V, "Effectiveness, tolerability, and dropout rates of vortioxetine in comorbid depression : a naturalistic study", Hum Psychopharmacol, 35, pp.e2750~ (2020)
- Sani G, "Koukopoulos ׳ diagnostic criteria for mixed depression : a validation study", J Affect Disord, 164, pp.14~18 (2014)
- Zimmerman M, "Measures of the DSM-5 mixed-features specifier of major depressive disorder", CNS Spectr, 22, pp.196~202 (2017)
- In Hee Shim, "Pharmacological Treatment of Major Depressive Episodes with Mixed Features: A Systematic Review", Clinical Psychopharmacology and Neuroscience, 16(4), pp.376~382 (2018), 대한정신약물학회[DOI]
- Koukopoulos A, "DSM-5 criteria for depression with mixed features : a farewell to mixed depression", Acta Psychiatr Scand, 129, pp.4~16 (2014)
- "Worsening depression and suicidality in patients being treated with antidepressant medications" (2004)[URL]
- Harada T, "Incidence and predictors of activation syndrome induced by antidepressants", Depress Anxiety, 25, pp.1014~1019 (2008)
- Hengartner MP, "Protracted withdrawal syndrome after stopping antidepressants : a descriptive quantitative analysis of consumer narratives from a large internet forum", Ther Adv Psychopharmacol, 10, pp.2045125320980573~ (2020)
- Kwok C, "Antidepressant-discontinuation mania in two patients with depression", Eur Psychiatry, 30(Suppl 1), pp.1591~ (2015)
- Narayan V, "Antidepressant discontinuation manic states : a critical review of the literature and suggested diagnostic criteria", J Psychopharmacol, 25, pp.306~313 (2011)
- Shiah IS, "Serotonin in mania and in the mechanism of action of mood stabilizers : a review of clinical studies", Bipolar Disord, 2, pp.77~92 (2000)
